EXC vs NXL · P/E 17, rev $24.26B vs rev $301.6K
Exelon Corporation (EXC) versus Nexalin Technology Inc. (NXL) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. NXL currently screens at market cap $8.5M.
Not investment advice. Open the EXC and NXL stock pages for the full models.
Not investment advice.